Activation of corneal fibroblast-derived matrix metalloproteinase-2 by tryptase

Current Eye Research

Volumn 31, Issue 4, 2006, Pages 313-317

  Yamamoto, Kazutaka ^a   Kumagai, Naoki ^a   Fukuda, Ken ^a   Fujitsu, Youichiro ^a   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corneal fibroblast; Matrix metalloproteinase 2; Tryptase; Vernal keratoconjunctivitis

Indexed keywords

GELATIN; GELATINASE A; PLASMIN; PLASMINOGEN; PROTEINASE ACTIVATED RECEPTOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRYPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CHILD; CORNEA; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CORNEAL STROMA; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRYPTASES;

EID: 33645784854     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680600629789     Document Type: Article

References (33)

1. Ueda J, Yue BYJT. Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes. Invest Ophthalmol Vis Sci. 2003;44:4772-4779.
2. Fini ME, Parks WC, Rinehart WB, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996;149:1287-1302.
3. Sivak JM, Fini ME. MMPs in the eye: Emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002;21:1-14.
4. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102:985-993.
5. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004;18:345-351.
6. Okada Y, Morodomi T, Enghild JJ, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem. 1990;194:721-730.
7. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992;267:21712-21719.
8. Kumagai N, Yamamoto K, Fukuda K, et al. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol. 2002;110:489-491.
9. Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy. 2005;4:177-181.
10. Schwartz LB, Bradford TR, Irani AM, et al. The major enzymes of human mast cell secretory granules. Am Rev Respir Dis. 1987;135:1186-1189.
11. Payne V, Kam PCA. Mast cell tryptase: A review of its physiology and clinical significance. Anaesthesia. 2004;59:695-703.
12. Tabbara KF. Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol. 2001;119:338-342.
13. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol. 1998;274:C1429-C1452.
14. Vliagoftis H, Schwingshackl A, Milne CD, et al. Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol. 2000;106:537-545.
15. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem. 1994;223:171-177.
16. Solomon A, Puxeddu I, Levi-Schaffer F. Fibrosis in ocular allergic inflammation: Recent concepts in the pathogenesis of ocular allergy. Curr Opin Allergy Clin Immunol. 2003;3:389-393.
17. Matsubara M, Girard MT, Kublin CL, et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol. 1991;147:425-439.
18. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290:S12-S23.
19. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 2000;41:1448-1453.
20. Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-α and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279:1-5.
21. Nagano T, Hao JL, Nakamura M, et al. Stimulatory effect of pseudomonal elastase on collagen degradation by cultured keratocytes. Invest Ophthalmol Vis Sci. 2001;42:1247-1253.
22. Cakarovski K, Leung JY, Restall C, et al. Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines. Int J Cancer. 2004;110:610-616.
23. Vergnolle N. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol. 1999;163:5064-5069.
24. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61-65.
25. Atkinson SJ, Crabbe T, Cowell S, et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem. 1995;270:30479-30485.
26. Butler GS, Butler MJ, Atkinson SJ, et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem. 1998;273:871-880.
27. Hernandez-Barrantes S, Toth M, Bernardo MM, et al. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem. 2000;275:12080-12089.
28. Will H, Atkinson SJ, Butler GS, et al. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem. 1996;271:17119-17123.
29. Ottino P, He J, Axelrad TW, Bazan HEP. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci. 2005;46:487-496.
30. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: Corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001;119:695-706.
31. Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Synergistic effect of TNF-α and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts. Cornea. 2003;22:557-561.
32. Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Expression of functional ICAM-1 on cultured human keratocytes induced by tumor necrosis factor-α. Jpn J Ophthalmol. 2003;47:134-141.
33. Corry DB, Rishi K, Kanellis J, et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol. 2002;3:347-353.